Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053683902> ?p ?o ?g. }
- W2053683902 endingPage "4840" @default.
- W2053683902 startingPage "4834" @default.
- W2053683902 abstract "Rituximab improves outcomes for persons with lymphoproliferative disorders and is increasingly used to treat immune-mediated illnesses. Recent reports describe 2 patients with systemic lupus erythematosus and 1 with rheumatoid arthritis who developed progressive multifocal leukoencephalopathy (PML) after rituximab treatment. We reviewed PML case descriptions among patients treated with rituximab from the Food and Drug Administration, the manufacturer, physicians, and a literature review from 1997 to 2008. Overall, 52 patients with lymphoproliferative disorders, 2 patients with systemic lupus erythematosus, 1 patient with rheumatoid arthritis, 1 patient with an idiopathic autoimmune pancytopenia, and 1 patient with immune thrombocytopenia developed PML after treatment with rituximab and other agents. Other treatments included hematopoietic stem cell transplantation (7 patients), purine analogs (26 patients), or alkylating agents (39 patients). One patient with an autoimmune hemolytic anemia developed PML after treatment with corticosteroids and rituximab, and 1 patient with an autoimmune pancytopenia developed PML after treatment with corticosteroids, azathioprine, and rituximab. Median time from last rituximab dose to PML diagnosis was 5.5 months. Median time to death after PML diagnosis was 2.0 months. The case-fatality rate was 90%. Awareness is needed of the potential for PML among rituximab-treated persons." @default.
- W2053683902 created "2016-06-24" @default.
- W2053683902 creator A5003670546 @default.
- W2053683902 creator A5013974745 @default.
- W2053683902 creator A5015087698 @default.
- W2053683902 creator A5019127443 @default.
- W2053683902 creator A5025688165 @default.
- W2053683902 creator A5031915216 @default.
- W2053683902 creator A5036848051 @default.
- W2053683902 creator A5037456539 @default.
- W2053683902 creator A5038012231 @default.
- W2053683902 creator A5046762831 @default.
- W2053683902 creator A5048895495 @default.
- W2053683902 creator A5049711954 @default.
- W2053683902 creator A5055266545 @default.
- W2053683902 creator A5061964017 @default.
- W2053683902 creator A5063153537 @default.
- W2053683902 creator A5064091455 @default.
- W2053683902 creator A5069033960 @default.
- W2053683902 creator A5073246821 @default.
- W2053683902 creator A5080373697 @default.
- W2053683902 creator A5081326206 @default.
- W2053683902 creator A5087980826 @default.
- W2053683902 creator A5089203948 @default.
- W2053683902 creator A5089300901 @default.
- W2053683902 creator A5089700881 @default.
- W2053683902 date "2009-05-14" @default.
- W2053683902 modified "2023-10-05" @default.
- W2053683902 title "Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project" @default.
- W2053683902 cites W1943449996 @default.
- W2053683902 cites W1965933196 @default.
- W2053683902 cites W1970547229 @default.
- W2053683902 cites W1972011758 @default.
- W2053683902 cites W1974438776 @default.
- W2053683902 cites W1981941163 @default.
- W2053683902 cites W1986002079 @default.
- W2053683902 cites W1994630947 @default.
- W2053683902 cites W1998362616 @default.
- W2053683902 cites W2000379621 @default.
- W2053683902 cites W2002558043 @default.
- W2053683902 cites W2006543057 @default.
- W2053683902 cites W2016051468 @default.
- W2053683902 cites W2022021091 @default.
- W2053683902 cites W2022669864 @default.
- W2053683902 cites W2024644107 @default.
- W2053683902 cites W2025597334 @default.
- W2053683902 cites W2036137768 @default.
- W2053683902 cites W2043104155 @default.
- W2053683902 cites W2043220369 @default.
- W2053683902 cites W2047595439 @default.
- W2053683902 cites W2051449571 @default.
- W2053683902 cites W2054425265 @default.
- W2053683902 cites W2058015212 @default.
- W2053683902 cites W2063489717 @default.
- W2053683902 cites W2066976900 @default.
- W2053683902 cites W2069416484 @default.
- W2053683902 cites W2072325046 @default.
- W2053683902 cites W2084718852 @default.
- W2053683902 cites W2085030852 @default.
- W2053683902 cites W2086983962 @default.
- W2053683902 cites W2089046185 @default.
- W2053683902 cites W2089100036 @default.
- W2053683902 cites W2089804020 @default.
- W2053683902 cites W2091851142 @default.
- W2053683902 cites W2096984838 @default.
- W2053683902 cites W2109553594 @default.
- W2053683902 cites W2123531724 @default.
- W2053683902 cites W2129481644 @default.
- W2053683902 cites W2134710462 @default.
- W2053683902 cites W2135321054 @default.
- W2053683902 cites W2136356615 @default.
- W2053683902 cites W2136991338 @default.
- W2053683902 cites W2140422101 @default.
- W2053683902 cites W2141111992 @default.
- W2053683902 cites W2155620154 @default.
- W2053683902 cites W2159095979 @default.
- W2053683902 cites W2160305510 @default.
- W2053683902 cites W2165229568 @default.
- W2053683902 cites W2167571754 @default.
- W2053683902 cites W2169726349 @default.
- W2053683902 cites W2224780480 @default.
- W2053683902 cites W2337885275 @default.
- W2053683902 cites W4210451846 @default.
- W2053683902 cites W4294826854 @default.
- W2053683902 doi "https://doi.org/10.1182/blood-2008-10-186999" @default.
- W2053683902 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2686134" @default.
- W2053683902 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19264918" @default.
- W2053683902 hasPublicationYear "2009" @default.
- W2053683902 type Work @default.
- W2053683902 sameAs 2053683902 @default.
- W2053683902 citedByCount "792" @default.
- W2053683902 countsByYear W20536839022012 @default.
- W2053683902 countsByYear W20536839022013 @default.
- W2053683902 countsByYear W20536839022014 @default.
- W2053683902 countsByYear W20536839022015 @default.
- W2053683902 countsByYear W20536839022016 @default.
- W2053683902 countsByYear W20536839022017 @default.
- W2053683902 countsByYear W20536839022018 @default.